• Most HCPs not aware of Accelerated Access Review – report pharmatimes
    September 18, 2017
    majority of health care professionals are not aware of the Accelerated Access Review or previous government-led initiatives aimed at improving the adoption of innovation across the NHS.
  • NHS negligence bill set to double pharmatimes
    September 08, 2017
    NHS negligence bills are set to double in less than five years, according to a new report by the National Audit Office.
  • NHS needs emergency £350 million to survive winter pharmafile
    September 05, 2017
    NHS Providers has stated that £350 million needs to be injected into the NHS to avoid the ‘humanitarian crisis’ that struck last winter.
  • Wales sees patients waiting more than a year for surgery up by 400% pharmatimes
    September 04, 2017
    On the NHS in Wales, the number of patients waiting in line for longer than a year for surgical treatment has rocketed over 4 times in 4 years.
  • NHS pumps £100m into GP recruitment as numbers plummet pharmafile
    September 04, 2017
    The NHS has been forced to offer £100 million to recruitment agencies in order to plug growing gaps in the number of GPs working in the service.
  • Final NHS green light for Allergan’s IBS-D drug pharmatimes
    September 01, 2017
    Allergan’s Truberzi has become the first treatment for irritable bowel syndrome with diarrhoea (IBS-D) to be reviewed and recommended by the National Institute for Health and Care Excellence for use on the NHS in England and Wales.
  • CMA clears Birmingham hospitals merger pharmatimes
    September 01, 2017
    The Competition and Markets Authority has cleared a merger between Heart of England NHS Foundation Trust (HEFT) and University Hospitals Birmingham NHS Foundation Trust (UHB).
  • NHS will pay £80bn for PFI contracts pharmatimes
    September 01, 2017
    Companies holding Private Finance Initiative contracts to build and run NHS hospitals have made £831 million in pre-tax profits over the past six years, money which could have reduced the deficit in NHS hospitals by a quarter over the period
  • NHS to assess data-recording insulin pen device pharmatimes
    August 30, 2017
    Up to 300 patients in England are to test a novel insulin pen accessory able to record usage data as part of a national NHS Test Bed programme exploring new models of care.
  • 3 in 4 of CDF treatments now approved on NHS pharmaceutical-technology
    August 16, 2017
    75% of cancer treatments previously accessible through the Cancer Drugs Fund (CDF) are now available for patients on the NHS England.
PharmaSources Customer Service